Hopefully the AGM will clarify the stumbling and bumbling by the analysts on the call.
Most positive take
Clock starts from this new data being submitted- presume the rest of the BLA is going at the same time
Heart partnerships WILL happen after the FDA meeting- no date set
Back- commence USA Q2, Europe Q3
Negative- Financials - drop in Temcell revenue.
Reg
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-6
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |